---
authors:
- Barry, Henry C
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/38574228/
file_path: 2024/03/amitriptyline-as-second-line-therapy-improves-symptoms-in-ad.md
issue: '3'
keywords:
- Amitriptyline
- Humans
- Irritable Bowel Syndrome
- Adult
last_updated: '2025-07-30'
mesh_terms:
- Adult
- Humans
- Amitriptyline
- Irritable Bowel Syndrome
original_format: PubMed
pages: Online
patient_population: Adults
peer_reviewed: true
pmid: '38574228'
processed_date: '2025-07-30'
publication_date: '2024-03-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-07-30'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Amitriptyline as Second-Line Therapy Improves Symptoms in Adults With Irritable Bowel Syndrome.
topics:
- Family Medicine
volume: '109'
---

# Amitriptyline as Second-Line Therapy Improves Symptoms in Adults With Irritable Bowel Syndrome.

**Authors:** Barry, Henry C

**Published in:** American family physician | Vol. 109, No. 3 | 2024-03-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/38574228/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Adult, Humans, Amitriptyline, Irritable Bowel Syndrome

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/38574228/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
